(1) Background: The World Health Organization Disability Assessment Schedule 2.0
(WHODAS 2.0) is a tool designed to measure disability in accordance with the International …

Background: Sarcopenia is a syndrome characteristic in elderly patients and is also
associated with a significant proportion of chronic disorders such as inflammatory bowel …

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing
health concern and the risk of its development is connected with the increasing prevalence …

Background Recent studies have suggested a relationship between gut microbiota and non-
alcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). However, the …

Diabetes mellitus (DM), due to its long-term hyperglycemia, leads to the accumulation of
advanced glycation end-products (AGEs), especially in the vessel walls. Skin …

Mitochondrial dysfunction, characterized by elevated oxidative stress, impaired energy
balance, and dysregulated mitochondrial dynamics, is a hallmark of metabolic syndrome …

Simple Summary Non-alcoholic fatty liver disease (NAFLD) has become a significant public
health concern, affecting over 30% of the population. The incidence of NAFLD-related …

Purpose The prevalence of metabolic syndrome (MetS) is increasing globally and has
become a global and national public health problem that cannot be ignored as an …

Background: Liver fibrosis arises from chronic hepatic injury and involves the accumulation
of extracellular matrix proteins. Fibrosis progression ultimately leads to cirrhosis …

Metabolic syndrome (MetS) is a group of metabolic abnormalities that identifies people at
risk for diabetes and cardiovascular disease. MetS is characterized by lipid disorders, and …